Acadian Asset Management
VYNT

Acadian Asset Management’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Acadian Asset Management’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-9,413
Closed -$130K – 2397
2020
Q4 		$130K Buy
9,413
+5,813
+161% +$85.9K ﹤0.01% 1673
2020
Q3 		$75K Buy
3,600
+2,928
+436% +$55.1K ﹤0.01% 1745
2020
Q2 		$10K Buy
+672
New +$10.5K ﹤0.01% 2170
2020
Q1 		– Sell
-672
Closed -$20K – 1983
2019
Q4 		$20K Buy
672
+401
+148% +$9.59K ﹤0.01% 1725
2019
Q3 		$4K Hold
271
– – ﹤0.01% 1823
2019
Q2 		$7K Buy
+271
New +$8.46K ﹤0.01% 1678
2015
Q4 		– Hold
0
– – – 1537
2015
Q3 		– Hold
0
– – – 1473

Other funds holding VYNT

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
QC
QCM Cayman Houston, Texas $3.63M AUM 61.13% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
CCT
Country Club Trust Kansas City, Missouri $1.27B AUM 22.67% 1-Year Est. Return

Acadian Asset Management's VYNT Position: Q1 2021 in Review

Acadian Asset Management sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q1 2021, closing a stake of 9,413 shares — an estimated $130K sold.

Acadian Asset Management first reported a position in VYNT in Q2 2019 and held it in 6 quarters. The position peaked at $130K in Q4 2020. 18 funds tracked by Wall St. Rank hold VYNT as of Q1 2021.

  • Acadian Asset Management reported no remaining Vyant Bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Acadian Asset Management sold 9,413 Vyant Bio, Inc. Common Stock shares in Q1 2021, an estimated $130K.
  • Acadian Asset Management first reported a position in Vyant Bio, Inc. Common Stock in Q2 2019 and held it in 6 quarters.
  • Acadian Asset Management's Vyant Bio, Inc. Common Stock position peaked at $130K in Q4 2020.
  • 18 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q1 2021.

Based on Acadian Asset Management's 13F filing for Q1 2021, filed 11 May 2021.